Loxapine
INDICATIONS
FDA
FDA
- Schizophrenia
- Psychomotor agitation; bipolar I disorder or schizophrenia (inhaled only)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Severe major depression with psychotic features
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: August 19, 2025
Citation
Qureshi, Imran. "Loxapine." Johns Hopkins Psychiatry Guide, The Johns Hopkins University, 2025. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787522/all/Loxapine.
Qureshi I. Loxapine. Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787522/all/Loxapine. Accessed October 8, 2025.
Qureshi, I. (2025). Loxapine. In Johns Hopkins Psychiatry Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787522/all/Loxapine
Qureshi I. Loxapine [Internet]. In: Johns Hopkins Psychiatry Guide. The Johns Hopkins University; 2025. [cited 2025 October 08]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787522/all/Loxapine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Loxapine
ID - 787522
A1 - Qureshi,Imran,PharmD, BCPP
Y1 - 2025/08/19/
BT - Johns Hopkins Psychiatry Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787522/all/Loxapine
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -